UBS Group »

Bionexus Gene Lab Corp shares owned by UBS Group

Quarter-by-quarter ownership of Bionexus Gene Lab Corp (BGLC) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Bionexus Gene Lab Corp

May 2024Jul 2024Sep 2024Nov 2024Jan 202510k20k30k50k100k
Value ($)Share countHistorical BGLC position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Bionexus Gene Lab Corp held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bionexus Gene Lab Corp by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $32k 110k 0.29
2024-09-30 $37k 83k 0.45
2024-03-31 $5.9k 8.4k 0.71

More positions owned by UBS Group

Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Meta Platforms Cl A Call Option (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
JPMorgan Chase & Co. Call Option (JPM)
Tesla Motors Call Option (TSLA)
Ubs Group SHS Call Option (UBS)
Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A Call Option (V)

View all positions for UBS Group

Top funds holding Bionexus Gene Lab Corp

UBS Group
XTX Topco
Geode Capital Management
Scientech Research
Jpmorgan Chase & Co
Morgan Stanley

View all funds holding Bionexus Gene Lab Corp